Research last month suggested that starting GLP-1 receptor agonist treatment in people with epilepsy and type 2 diabetes was ...

As people with type 1 diabetes live longer than ever before, both clinicians and patients are recognizing the need to prepare ...

For almost two-thirds of his life, Nick Jonas has lived with a chronic condition — type 1 diabetes. The Jonas Brothers-famed ...

Children with a high genetic risk for type 2 diabetes who were also exposed to maternal gestational diabetes are more likely ...

GLP-1 receptor agonists are associated with a lower risk of dementia than DPP-4 inhibitors in dialysis patients with diabetes.

AIIMS Delhi reports metabolic surgery helps many with uncontrolled Type-2 diabetes; 30% stopped meds. Early intervention ...

The study thus suggests yet another unexpected avenue for the GLP-1 drugs.

Five diabetes subgroups (MARD, MOD, SAID, SIDD, SIRD) have specific comorbidity and mortality risk profiles, study results show.

Launch targets $16 billion SGLT-2 inhibitor market that serves 33 million type II diabetics in the US, many of whom are ...

Sribharath said the situation is reflected in Visakhapatnam too, where hundreds of children are living with the condition.

A new review of nearly 100,000 participants suggests that glucagon-like peptide-1 receptor agonists (GLP-1RAs), popular ...